Replies to post #127421 on Biotech Values

[biomaven0]

I've mostly been trading PYMX (but not in any size) rather than just holding it. Currently do hold a very modest position acquired around current prices.

Peter

[DewDiligence]

MDCO seeks a different way of “reversing” heparin following CABG surgery:

http://finance.yahoo.com/news/The-Medicines-Company-MDCO-iw-1444860571.html?x=0

MDCO-2010 is an antifibrinolytic, i.e. it inhibits the inhibition of clot formation, which thereby reduces blood loss. Paradoxically, MDCO-2010 is also an anticoagulant, but its anticoagulant activity is apparently weak enough to not cause a problem.